Skip to main content

Table 2 Schematic diagram of part B

From: Efficacy and safety of Qing-Feng-Gan-Ke Granules in patients with postinfectious cough: study protocol of a novel-design phase III placebo-controlled, double-blind randomized trial

Phase

Supervision period

Time-point

Baseline

Visit 1

Visit 2

Visit 3

Day

0

6 ± 1

11 ± 1

Follow-up

Basic history collection

×

   

 Informed consent

×

   

 Demographics

×

   

 Enrollment based on the inclusion/exclusion criteria

×

   

 Coexisting diseases or symptoms

×

   

 Concomitant treatments

 

×

×

 

Efficacy evaluation

    

 Cough symptom score

×

×

×

×

 Cough VAS score

×

×

×

 

 TCM syndrome score

×

×

×

 

 CQLQ

×

 

×

 

Safety evaluation

    

 Vital signs

×

×

×

 

 Blood routine and urine routine

×

 

×

 

 Liver function (ALT, AST, STB, ALP, γ-GT )

×

 

×

 

 Renal function (Cr, BUN)

×

 

×

 

 ECG

×

 

×

 

 Adverse events

 

×

×

 

Screening tests

    

 CR

×

   

 BPT

×

   

 UPT (women of childbearing age)

×

   

Other steps

    

 Randomization allocation

×

   

 Drug distribution

×

   

Remaining drug count

  

×

 

Patient record card distribution/recycling

×

 

×